Your questions / what the tests show
Your treatment questions need different kinds of tests
Can a study choose your treatment? No, the research doesn't know your health. You can learn what was tested.
Semaglutide's gut-hormone copy changes hunger and sugar
What does semaglutide copy? GLP-1, released from your gut after meals, helps control hunger and sugar. Semaglutide acts like GLP-1 for longer and helps release insulin to lower sugar. Semaglutide is in Ozempic and Wegovy, though the names aren't product endorsements.
Allowed semaglutide uses depend on the exact medicine
Long-term weight control and type 2 diabetes are among the allowed uses. The exact medicine label tells you which uses are allowed. One trial found less serious heart illness in heavier patients already facing heart disease [3]. Another tested lasting kidney illness with type 2 diabetes [2].
Approval is like a driving license naming permitted vehicles. Permission for one vehicle doesn't extend to every other vehicle. Likewise, one allowed use doesn't cover all your health concerns.
Semaglutide affects sugar control and how slowly your stomach empties
Semaglutide copies GLP-1, helping insulin release as sugar in your blood increases. With insulin, cells can draw sugar out of the bloodstream. Semaglutide limits another hormone's sugar-raising effect and slows your stomach, changing hunger. The changed drug lasts longer in your blood than the natural hormone GLP-1.
Semaglutide weight loss mainly came from eating less
Twenty twenty-one: STEP 1 studied adults without diabetes carrying excess weight. Average changes at 68 weeks were −14.9% with semaglutide and −2.4% with placebo, made without any active medicine [4]. Both minus signs mean loss, with more loss on semaglutide. Eating less explains most of the effect, but doesn't measure your strength.
Tesamorelin treats a particular fat problem linked with HIV
Your gland responds to tesamorelin by sending out more growth hormone. Your gland supplies the hormone, so this isn't a replacement hormone shot. Approval concerns unusual belly-fat storage in adults with HIV [7]. HIV harms the immune system, and this fat problem isn't ordinary weight gain.
Tesamorelin trials found less liver and deep belly fat
Growth hormone rises with tesamorelin, along with a further hormone that helps growth. Fat collected unusually in the tested adults because of HIV. Liver fat, deep belly fat and chest-and-belly fat fell [6]. Muscle, organ and water weight rose together, which doesn't prove muscle growth for you.
Growth hormone comes from your gland when tesamorelin prompts release
Growth hormone release increases after tesamorelin prompts your pituitary gland (below the brain). The hormone then makes your liver produce another hormone that helps growth. Together, those changes help your body break down fat. That's different from a shot supplying growth hormone directly.
Belly-fat trials cannot forecast your own weight change
Your own fat loss can't be forecast from tesamorelin trials. Deep fat fell in adults with changes in fat storage related to HIV [6][8][11]. Researchers haven't proved the same benefit in everyone carrying extra weight. Fat also returned after stopping treatment [10], so loss didn't always last.
MOTS-c changed cells and mice without proving benefits for people
MOTS-c entered the nucleus (the part holding most DNA) when cells struggled to make energy [17]. Cells changed their use of DNA instructions for sugar use and defenses against harmful chemicals. Treated mice's muscles used sugar better, shrank less and moved better [13][16]. The same gains aren't proved for human treatment.
Human side effects remain uncertain without enough treatment tests
Your side-effect question needs tests of people receiving MOTS-c. Researchers haven't adequately counted harms after treatment in people. Mice and cells can't give you those missing human harm rates. Few reported problems don't establish safety when treatment hasn't been tested adequately.
MOTS-c approval and sports rules limit possible use
FDA is the United States agency that approves medicines. That agency hasn't approved any human treatment use for MOTS-c. The sports ban applies to athletes competing or between competitions. Rules about research and sale can differ by place, so you won't find purchase advice here.
Research has not established human MOTS-c amounts or timing
There isn't an approved plan for treating people with MOTS-c. Studies haven't settled human amounts or how your body handles the substance. Mouse tests can't establish safe human shots. You won't find amounts or treatment directions here.